Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$120.0 - $182.95 $5.06 Million - $7.72 Million
42,204 New
42,204 $5.32 Million
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $37.3 Million - $59.6 Million
-232,804 Reduced 92.49%
18,912 $3.54 Million
Q2 2022

Aug 12, 2022

BUY
$140.68 - $188.02 $4.35 Million - $5.81 Million
30,900 Added 13.99%
251,716 $40.9 Million
Q1 2022

May 13, 2022

BUY
$161.19 - $257.96 $7.11 Million - $11.4 Million
44,100 Added 24.96%
220,816 $41.5 Million
Q4 2021

Feb 11, 2022

SELL
$247.59 - $304.47 $4.83 Million - $5.94 Million
-19,496 Reduced 9.94%
176,716 $46.8 Million
Q3 2021

Nov 12, 2021

SELL
$194.77 - $324.21 $31.2 Million - $51.9 Million
-160,004 Reduced 44.92%
196,212 $56.7 Million
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $17.5 Million - $23.4 Million
-105,796 Reduced 22.9%
356,216 $71.1 Million
Q1 2021

May 13, 2021

SELL
$180.37 - $226.26 $37 Million - $46.4 Million
-205,032 Reduced 30.74%
462,012 $89.8 Million
Q4 2020

Feb 10, 2021

SELL
$148.08 - $206.57 $33.7 Million - $47 Million
-227,293 Reduced 25.41%
667,044 $128 Million
Q3 2020

Nov 13, 2020

BUY
$122.51 - $158.27 $26.5 Million - $34.2 Million
216,304 Added 31.9%
894,337 $132 Million
Q2 2020

Aug 13, 2020

BUY
$94.33 - $140.48 $28.2 Million - $42 Million
299,300 Added 79.03%
678,033 $83.8 Million
Q1 2020

May 14, 2020

BUY
$84.96 - $109.14 $11.4 Million - $14.7 Million
134,401 Added 55.01%
378,733 $36.6 Million
Q4 2019

Feb 13, 2020

BUY
$73.84 - $93.08 $1.04 Million - $1.31 Million
14,028 Added 6.09%
244,332 $22.6 Million
Q3 2019

Nov 13, 2019

BUY
$76.65 - $95.51 $12.7 Million - $15.8 Million
165,704 Added 256.51%
230,304 $17.7 Million
Q2 2019

Aug 12, 2019

SELL
$54.2 - $85.95 $4.74 Million - $7.51 Million
-87,404 Reduced 57.5%
64,600 $5.55 Million
Q1 2019

May 14, 2019

BUY
$49.45 - $62.8 $2.37 Million - $3.01 Million
47,900 Added 46.01%
152,004 $8.98 Million
Q4 2018

Feb 13, 2019

BUY
$48.26 - $68.88 $5.02 Million - $7.17 Million
104,104 New
104,104 $5.49 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.